Cuprina Holdings (cayman) vs Heartsciences
Cuprina Holdings (cayman) is the larger business, with $38,204 of revenue in fiscal 2025 against $4,319 for Heartsciences (8.8 times as much). Cuprina Holdings (cayman) grew faster (5.6% against -0.7%). Cuprina Holdings (cayman) kept more of each dollar of sales as profit: a net margin of -9366.8% against -211666.5%.
| Latest fiscal year | Cuprina Holdings (cayman)CUPR, 2025 | HeartsciencesHSCS, 2026 |
|---|---|---|
| Revenue | $38,204 | $4,319 |
| Revenue growth | 5.6% | -0.7% |
| Net income | −$3.6m | −$9.1m |
| Operating margin | — | -194787.4% |
| Net margin | -9366.8% | -211666.5% |
| Return on equity | — | — |
| Free cash flow | −$7.0m | −$7.4m |
| Cash | $2.4m | $1.7m |
| Total debt | $128,260 | $3.6m |
| Debt to equity | — | 1602.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 14 |
| Market value | $37.9m | $11.6m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |